The shingles vaccine called HZ/su doesn’t make you more likely to have serious health problems, autoimmune issues, or die compared to getting a fake shot — even after tracking people for over three years.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
This claim is based on a well-designed randomized controlled trial (RCT) with long-term follow-up, which is the gold standard for assessing causal safety effects of vaccines. The claim uses precise language ('does not increase') and specifies population, comparator, outcomes, and duration — all critical for causal inference. The null result (no increased risk) is appropriately framed as a definitive conclusion because the study had sufficient power to detect clinically meaningful differences in rare but serious outcomes. The use of 'potential immune-mediated diseases' is cautious and scientifically valid, as these are often identified through surveillance rather than direct causation.
More Accurate Statement
“In adults aged 50 and older without immunosuppression, the adjuvanted herpes zoster subunit vaccine (HZ/su) does not confer a statistically significant increase in the incidence of serious adverse events, potential immune-mediated diseases, or all-cause mortality compared to placebo over a mean follow-up period of 3.5 years.”
Context Details
Domain
medicine
Population
human
Subject
The adjuvanted herpes zoster subunit vaccine (HZ/su)
Action
does not increase
Target
the risk of serious adverse events, potential immune-mediated diseases, or death
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
This big study gave the shingles vaccine to thousands of older adults and compared them to people who got a fake shot. After more than three years, the vaccine group didn’t have more serious health problems or deaths than the placebo group, so the vaccine is safe.